Reddit Posts
MDAI - “We are pleased to reach this milestone towards the initial commercialization opportunity for our DeepView AI®-Burn algorithm."
MDAI - announced the submission of an application in the United Kingdom for its predictive software DeepView AI®-Burn to be registered as UK Conformity Assessed (UKCA) for burn wound use in the UK.
MDAI - The DeepView® Wound Imaging System
MDAI nice day to accumulate with FDA pending news
MDAI nice day to accumulate with FDA pending news FDA
MDAI nice opportunity to load up today
MDAI nice week ahead...enjoy the ride
MDAI in the last post I forgot to post CTB situation
MDAI has only 240k float with 50% SI and CTB around 300%
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%.
MDAI...These things don't happen often..240k float with 50% SI and CTB around 300%..
NEGG lot of spamming posts by shorters...hope you took your profits. If you are looking for a nice squeeze MDAI is one of the best. The new hype is here.
Did you load up some MDAI in the last days...?
MDAI where could go with the squeeze and the news incoming?
MDAI very tiny float..high SI.. CTB around 300% and news incoming
MDAI accumulation is ending..nice squeeze incoming
Hope you loaded up enough MDAI 2 days ago... squeeze incoming
MDAI very tiny float ..high SI and CTB around 300%
MDAI could pop hard today with tiny float
Penny stocks to watch now? 4 turning heads this week
$MDAI micro float with +$100M in contracts
Mentions
Thank you! I’m only in MDAI and COCH that need FDA approval for anything.
MDAI a solid legitimate opportunity
MDAI . and PDYN - that betch wanna squeeeze ! 🍋 
MDAI 🤌🏻 
So you think a stock rising this much before FDA approval won’t rise much more? Or it won’t rise enough to be worth the upside? The FDA approval is going to be a major catalyst as you have seen in here time and time again. There will be a big boom and bust. So use that event to pay off the shares you want to keep because it will most likely fall right back down. I still think it will be higher than whatever you enter at today, but no promises. But just DCA into it if you are worried. You don’t have to do large lump sums and you definitely can swing trade shares to get a better cost average over time. A recent biotech that got FDA approval is MBOT, so you can look at them as a potential reference point for the pre-FDA approval run up, the approval, the drop, the climb back up. But for more specific help and insights on MDAI, go to the MDAI Reddits. One of them uses the name Spectral AI in the name. The great news is, the US military wants this product ASAP. That is your main commercialization driver and funder. Hopefully it will lead to a less dilutive commercialization effort. They won’t have to fight tooth and nail for those first sales. They’re pretty much in the bag. The product is also highly touted by those who’ve used it for trials overseas, which is why confidence is high that Spectral AI’s tech will be approved. It’s not invasive or dangerous. The reliability of the AI is the main concern on this one. It also already made it into Time Magazine for one of the best techs in healthcare. You’re never going to find a unicorn of a stock that can avoid dilution. Execs want to be paid in stock. Mergers or acquisitions will have dilution. Getting into the Russell index will sometimes require some dilution to have more shares available to trade. Commercialization is expensive. Scaling up is expensive. Building a few MDAI units is peanuts to building thousands of them and providing software help. It’s all just a part is the journey, and this is where you pay a lot more attention to if they are being good stewards with the extra capital and doing their best to get financing on good terms instead of on toxic debt terms. The MDAI Reddit’s have timelines, videos, etc. MDAI is already working it overseas while waiting on FDA approval here. They aren’t just sitting on their hands or anything. They are already getting the word out. Spectral is a great company. Just a very quiet company. But they do make the most of every opportunity in the conferences they go to it seems like. Share prices seem to always go up after one. The main issue as a shareholder is how much money you want to have tied up while waiting on FDA approval and commercialization. I used to have 750 - 1000 shares depending on the month. I trimmed down to 100. When it’s closer to FDA approval is when I’ll load up. I just don’t want a ton of cash tied up dead for months and months. I won’t have the best cost basis, but I’ll make that money up on all the trading done on other stocks between now and then. MDAI is going go be a long term hold no matter what, just like MBOT.
Not for today but for the next year - MDAI
MDAI - govt funded med device utilizing ai to treat wounds. Already has traction in Europe and likely buyout target
Legend has it that this is the group that helps those in need by pumping their heavy baggings. The following are my bags. Please pump: IINN, MDAI, XAIR, LFMD. Thank you in advance.
Any penny stocks out there that aren't pump and dumps? Long term hold, good growth potential. What are your thoughts on MDAI?
MDAI de-SPACed in Sept. 2023.
Pretty sure his take is to the moon, why else would he be all in otherwise? I haven't seen MDAI much just saw the chart, why was there a 80% fall in September 2023?
Im basically all in on MDAI so i like the sound of this
GRAL will keep pumping, then maybe MDAI
MDAI https://preview.redd.it/fajxwo2i6atf1.jpeg?width=1320&format=pjpg&auto=webp&s=69775ad166f5c7b77c871730d9e3605314228071
Maybe MDAI, maybe not. Could be 6 mos.
$MDAI is undervalued and a hidden gem. Stoked to see you all get into it with me and make some $$$
MDAI - Skow and steady for sustained moves higher
I’ve got 3k shares in MDAI. It’s an amazing concept and they’re getting good results. I think it’ll be a longer hold though as it’s mode ling takes time and there’s a lot of process to go through
OPEN and RIGETTI blowing up setting the stage for MDAI QD and INNODATA to set the tone for the market big home run with COPX to compliment the demand as an increase in utility. Next move on to production stocks and manufacturers with the mindset on material costs and expenses like gas oil (i.e energy) for sure wish I bought more INNO. With a spike today going to 82! Calling out MDAI 👀. Let’s goo !! QD 🍑god like platform structure..don’t sleep on that pharma market 🤫 😴 💊 Follow for more mentions on the market
MDAI is the heavy sleeper buying 500 more to get the most gain next week
I will be topping up LUNR, MDAI & UPST shortly!
$MDAI going unnoticed by the masses
MDAI continues to solidify - primed for a takeout target
Whoa baby GRAL cranking today. MATV basing. Let's see what happens with MDAI.
MDAI - not next week but certainly over next few months with fda approval and greater visibility
Interesting video from MDAI CEO and founder https://youtu.be/cGktsfcfYSM
MDAI. Maybe not for today but definitely over next 3-6 months. Hard to predict when it really starts ramping, could be any day
MDAI continuing to build a good chart with good fundamentals
MDAI easy double up (minimum) in 6 months at approval.
Solid lineup here. I actually dug deeper into these names over the weekend, and the risk/reward looks very favorable short-term. NXXT especially stands out — the Florida land + 200MW grid deal isn’t just hype, that’s real infrastructure value, and the CEO insider buy is a textbook signal. NVNI’s recent acquisitions + earnings momentum could easily fuel the $7–12 target chatter. Even ASST looks like a sleeper with those institutional stakes quietly positioning. MDAI is slower, but the FDA angle with such a tiny market cap vs TAM is exactly the kind of asymmetry that pays big if it hits. HOLO’s the only wild card, but if sentiment turns risk-on, squeezes there can be brutal. Overall I see multiple near-term catalysts — wouldn’t be surprised if 2–3 of these names outperform hard in the next leg up.
Nice to see MDAI move up slow and steady as fda approval looms. $65m market cap with a product slated to address a 15b market opportunity. And history of insider buying.
I’m in MDAI from like a week ago
I have recently bought LUNR, MDAI and UPST for my new ‘[Less than $10k to $1 million](https://www.reddit.com/r/DoubleBubbler/comments/1lvkwxs/less_than_10k_to_1_million_current_value_since/)’ challenge.
Spectral AI (MDAI) Waiting on FDA approval and named in the TIME’s list of top HealthTech companies 2025
MDAI anyone? I’ve been in for like a week or two. I got in at 1.9, at 2.4 now
https://preview.redd.it/b9z5xng5z4qf1.jpeg?width=743&format=pjpg&auto=webp&s=41f28123ef472e89b4e90fd2f17d6564611e5a5c MDAI
Imma put y'all on: $MDAI So much potential!
MDAI , USAS , PDYN 🤌🏻 
https://preview.redd.it/eh13t66huqpf1.jpeg?width=1280&format=pjpg&auto=webp&s=1e5621778d77bbe23356bfc366f397b655cc0fed MDAI 🤌🏻
Im literally done. Placed in voo and voog. Only risky stock i have is MDAI which i know will pay off in a couple years. But the anxiety i get in options is not worth it. Was up 60% (4.2k) on ETHA last friday only to close it today at +5% fml
What do we think about MDAI ?
SKYX , USAS , RR , MDAI 
HIT is profitable. They have already moved a lot though. Most pennies aren’t profitable hence the high risk high reward attractiveness of them. SLS, MDAI, PFSA is what I’m in. PFSA should be noted seems to have a bad reputation here from back in June. But they seem legit and just announced integration of AI utilizing NVIDIA chips to streamline data workflow for the doctors. So take this one with a grain of salt. MDAI and SLS buy the fuck out of.
I found here IXHL, OPEN, VAPE ( now BNC) NXTT, MDAI, ATYR, CVVY, ELTP and recently SONM. How the fuck anyone here is unprofitable. All of thos were profitable for me. Of course, if I would have gone all in in them I would be much richer, but I still need to work with my psyshology and not sell my winner to early. Otherwise this is just gold mine IMHO.
Idk 🤷♂️ I’m not a crystal ball. I’m also in SLS and MDAI and it’s a game a patience. With this one maybe earnings, but otherwise I’m just being patient because I have a gut feeling there’s more than meets the eye with this one and the above slight analysis included. There’s a reason I only threw 5k at this one and have 20k in SLS and 10k in MDAI. I invest based on my confidence in the company’s growth potential. Or fall potential. Still invested but less of a sure thing to me as the others.
Hi ! MDAI (Spectral AI, Inc.) • Uses AI for predictive diagnostics like the DeepView® system to improve medical decisions. • Stock focus: AI-powered medical diagnostics / healthcare tech. • Profitability: Not profitable — Net loss of ~–$14.3M over the past 12 months; Q2 2025 net loss of $7.9M. ⸻ PERF (Perfect Corp.) • Offers AI/AR SaaS solutions for beauty and fashion, including YouCam virtual try-on. • Stock focus: AI-driven beauty tech / SaaS. • Profitability: Currently profitable — Net income of $0.2M in Q2 2025; $2.5M profit in H1 2025. ⸻ PSTV (Plus Therapeutics, Inc.) • Develops targeted radiotherapeutics for difficult-to-treat cancers, such as in the central nervous system. • Stock focus: Biotech / oncology radiotherapeutics. • Profitability: Recently turned profitable — Net income ~$5.2M in Q2 2025 after years of losses. ⸻ INVZ (Innoviz Technologies Ltd.) • Builds solid-state LiDAR sensors and perception software for autonomous vehicles, drones, and robotics. • Stock focus: Autonomous vehicle technology / LiDAR sensors. • Profitability: Not profitable — Losses of ~$74.6M in the last 12 months; margins deeply negative. ⸻ BZAI (Blaize Holdings, Inc.) • Develops AI edge-computing hardware and software, including programmable AI processors for real-time applications. • Stock focus: AI semiconductors / edge computing. • Profitability: Not profitable — Net loss of ~–$209.7M over the past 12 months; Q2 2025 loss $29.6M. ⸻ ZMDTF (Zoomd Technologies Ltd.) • Provides a MarTech SaaS platform for unified user acquisition and engagement across digital and mobile channels. • Stock focus: AdTech / MarTech SaaS. • Profitability: Profitable and growing strongly — Net income $6.1M in Q2 2025; ~24.5% profit margin. ⚠️ Disclaimer: These summaries are AI-generated based on publicly available financial data and may not reflect the latest company filings. This is not financial advice. Always do your own due diligence or consult a licensed financial advisor before making investment decisions.
The one penny stock I actually pulled the trigger on that I saw here is MDAI. Im down like 25% but I still have quite a bit of conviction in it. Just look up the ticker or "spectral ai" in the sub search bar, and there's been quite a bit of DD posted. I think sub $2 is a steal if you have some gambling money to burn
A few medical tangent plays. All awaiting FDA soon. But not meds. MBOT robot cardiovascular MDAI AI modeling for burn treatment INBS fingerprint drug testing Also a TOTAL wildcard out there idea. GPRO They began offering user videos to be sold for AI training and modeling. Users get paid and they get a cut. It’s a new revenue stream that could be a turn around for them… maybe.
Oh yeah... $MDAI 3rd trial clearance soon.
Loaded up on GRAL, MATV, MDAI
Never give up. Stop listening to this sub and dyor. Take your money and invest it in good stocks. ICU SESI SGBX BBAI OSS MDAI RZLV LXRX VOR KSCP.. and the list goes on. Youll see ups and downs but youll be confident and less stressed in holding a bit longer and seeing actual results. Everyone here is waiting for a pump and dump. Get out of the cracked out rat race going on here.. good luck my friend.
MDAI. Trust me! Just check the company from top to bottom. But understand that they are providing something that fits a need, reduces costs, and specifically meets hospital needs, especially with hospitals shouldering the brunt of future costs, due to recent trump bill Just remember to thank me in the first quarter of next year!
RDZN , RR , MDAI , USAS , SKYX 
$BTAI * Inputs: fragile revenue, expensive trials, AI hype. * Process: clinical data → investor sentiment swing. * Output: binary price dynamics: explosive if positive trial outcomes; implosion if not. **Concise Verdict:** * **Structural posture:** High-risk speculative biotech. Upside only plausible with robust Phase 3 success or FDA progress. * **Action Guidance:** Suitable only for speculative trading or watchlist. If one positions, tight risk control essential. $ATYR * Inputs: negligible current revenue, early clinical pipeline. * Process: trial outcomes → speculation cycles. * Output: price swings contingent on success signals; structural instability persists until proof of efficacy. **Concise Verdict:** * **Structural posture:** High-risk clinical development. Potential upside with positive data, but execution risk high. * **Action Guidance:** View as speculative watchlist candidate. Allocate only if monitoring trial progress and financing clarity. **$MDAI** * Inputs: device validation progress, funding, regulatory tensions. * Process: signaling through filings and FDA interactions. * Output: volatile investor sentiment; upside tied to commercialization; downside amplifies if regulation stalls. **Concise Verdict:** * **Structural posture:** High-speculation frontier tech. Mixed signals—some execution upside, overshadowed by volatility and potential manipulation complexity. * **Action Guidance:** Recommended as a watchlist asset. Only consider small speculative position; require strict monitoring of FDA milestones and regulatory resolution.
Would love your analysis of the following: BTAI ATYR MDAI
Who lit the fuse on MDAI? Lovely!
MDAI , been in it to win it 🤌🏻
SKYcoX and MDAI earnings coming up after market close. Im ready for more Pain 😭💀 Today's been brutal man 😖 
It is certainly chat-gpt and someone holding some bags I have no doubt but MDAI is a great company.
I ended putting my extra money into MDAI instead of BBAI -- fundamentals be damned for BBAI ig
 MDAI 📉
CTM new today : [https://www.stocktitan.net/news/CTM/castellum-inc-teams-with-quarrio-to-provide-trustworthy-agentic-ai-ssr2v9gxdj2m.html](https://www.stocktitan.net/news/CTM/castellum-inc-teams-with-quarrio-to-provide-trustworthy-agentic-ai-ssr2v9gxdj2m.html) SKYX and MDAI : Earnings today 
MDAI - smile and wave boys. Smile and wave. 👋
SKYX and MDAI . Earnings this Tuesday USAS - Precious metals
PDYN , RCAT , SKYX , CTM , USAS , MDAI , RR , GORO 
I'm a big fan of $ONDS and $MDAI, and I'm keeping an eye on $RR
That's amazingg! 🌟 x2 my investment this year with RKLB, AMDL & MDAI.. along with a few others. I got shares of First Mining Gold at 0.168. Would love to see what else you're interested in! I have a screenshot of Keith Neumeyer (First majestic silver & First mining gold founder), who bought about 1M dollars worth of shares total in the last year. That's really what got me invested into First mining. The guy knows what he's doing and I strongly believe in his vision. Best of luck to us!
MDAI - huge potential. Over 90% accuracy of the device for burn diagnosis (as per previous year clinical trial), which beat human diagnose accuracy by 30%. The DeepView could be applied for many other cases (like diabetic uclers). Waiting FDA approval by the end of 2025.
CTM/GORO/USAS/MDAI stop trading bio pharma if you wanna keep your money
Funny because I have been posting MDAI during the lows… since August last year when the stock was $1, and consistently since then. This subreddit just tends to jump on active growth stories rather than turnarounds. In my opinion, this is still a narrative turnaround, the very likely FDA approval odds are not sufficiently priced in.
That’s good. I sold yesterday and will pick it back up when it’s in the $26.xx range or lower. I’m going for cheaper stuff right now, ONDS, VERI, UAMY, LIDR, PL, and MDAI. Essentially I’m going where government funding or contracts are going for penny stocks. UAMY will hopefully get what they need soon to keep expanding their smelting operation for antimony. Some other stocks that have been doing well since I sold out of them are LITE, CIEN, and GLW. GLW had good earnings recently. I might get back into these myself on a pullback, but I’m just trying to not stretch myself too thin with the macro economy in flux like it is.
Stop chasing this stuff. I will give you one good suggestion, and I've done a TOPN of work on this company. stock is MDAI ( Spectral AI). Put all of your money into it, but DO NOT look at it for at least the next 2+ years. This is a company that fits a need, especially with hospitals taking on the brunt of the work , thanks to Trump's bill. The device is getting great reviews, and the word of mouth has already placed it in hospitals in Australia ( for trial and feedback for now). FDA approval might come before the end of this year. I've looked into the whole management. The former CEO ( still has the most shares) spun off a company called SIM IP. This guy knows how to make money from patents sitting collecting dust. If you buy MDAI, you will get a small share of their spinoff. I've spoken with people that have used the device at hospitals, and they have said its a game changer.. and once it is in hand-held devices,... look out. Nobody will be able to replicate them for at least 15 years ( because of patents). Do your own research.. but that is my suggestion to you
quite a few MDAI DD are available on this sub. Thought I’ll give it a go
Buying MDAI. ER next week
Check this out , there's a total of 8 videos , Answers everything from Finances, to FDA Approval , Army handheld device , etc . from A-Z [interview with Spectral AI's Chairman of the Board, Dr. J. Michael DiMaio](https://youtu.be/cGktsfcfYSM) [MDAI : Finances](https://www.youtube.com/watch?v=R6RdtHfjs98&t=94s) [Spectral AI's DeepView FDA Submission Process](https://youtu.be/25nbD9FZIjs) And from what I understand MDAI shareholders will get free shares of the new IPO SMIP (Spectral IP) of which Trump Jr. is on the board. For better or worse lol , you be the judge
Here is what I think * Their debt is about 70% of their Total Cash * Analysts' average is \~ $5 (that's currently a 2.1x bagger) * Insider purchases are strong (14k shares purchased to 0 sold) * [Their TAM is $2-$3B (burns niche)](https://www.reddit.com/r/pennystocks/comments/1mh8feb/comment/n6ufhlb/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button), which is still very attractive since they don't seem to have competitors in their niche \- They've just sent their device to the FDA, a possible approval will only work as a **catalyst between 12/2025 to Q1 2026**. I would have probably scooped a few shares for shits and giggles when they PPS was around $1.20. We are currently at $2.36, which is [historically almost higher than it has ever been](https://finance.yahoo.com/quote/MDAI/) (if you don't count two pump spikes). The PPS needs to come down in order for me to increase Margin of Safety.
Could chat GPT write up. But here's what ChatGPT says. The screenshots you’ve shared paint a very bullish picture of Spectral AI ($MDAI) — but the tone and structure read more like a promotional pitch than an objective analysis, so I’d be careful before making decisions. Here’s my breakdown: The Bullish Case (as presented) Technology & Accuracy DeepView® AI imaging claims 95.3% accuracy in identifying surgical burn depth, significantly higher than trained surgeons. Non-invasive, no patient contact, proven in multicenter trials. Already used in military/trauma contexts with U.S. DoD interest. Government & FDA Position Over $130M in non-dilutive government funding. Holds FDA Breakthrough Device Designation and has filed a De Novo submission (June 30, 2025). Contract with the U.S. Department of Defense for battlefield/trauma integration. Financial & Market Potential Q2 earnings due August 12th (less than two weeks away). Last quarter was their first profitable quarter ($6.7M revenue / $2.9M net). Market cap only ~$54–60M with claims of a $14.6B total addressable market. No current direct competitors. Extra Catalyst Possible spin-off (SMIP) with separate Nasdaq IPO. Shareholders may receive spin-off shares. The author frames this as a "first-mover monopoly" situation. The Risks & Red Flags Source & Tone This post is clearly written to hype. The language is promotional (“this won’t last,” “monopoly,” “door to serious capital”). That’s typical of penny stock forums and can be a sign of someone talking their own book. No mention of risks like FDA delays, competition, or cash burn rates. Regulatory Uncertainty FDA submission ≠ approval. The process can take months or even years. A delay or rejection could tank the stock. Commercialization Risk Even with great trial results, adoption in healthcare is slow. Hospitals, burn centers, and military procurement have long sales cycles. Market size estimates ($14.6B) may be overly optimistic — not every wound care setting will adopt immediately. Microcap Volatility ~$54M market cap means extreme price swings on relatively small volume. If insiders, institutions, or hype traders dump shares, price could collapse quickly. Spin-off Hype Spin-offs can be good, but they can also be overhyped to boost the parent company’s stock short term. Little detail is given about SMIP’s actual revenue, market readiness, or financials. Balanced View Potential Upside: If the FDA approves DeepView and adoption happens even modestly, the stock could move sharply higher from current levels. Real Risks: Approval isn’t guaranteed, commercialization will take time, and hype-driven buying could reverse violently. Investment Type: This is a speculative microcap biotech/medtech play — not a safe, steady investment. You’d only allocate money you’re willing to lose entirely. If you want, I can dig up current analyst sentiment, institutional ownership, and recent SEC filings for $MDAI so you’ll have a more grounded, less Reddit-hyped picture before deciding. Do you want me to do that next?
No one mentioned MDAI? They’re expecting FDA approval for their Deepview device. Look it up! It’s expected to be approved in Q3 2025, hopefully sometime this month. There are a few DDs by some folks in this sub, as well as MDAI sub. Very insightful!
I’m in CTM, RZLV, MDAI, GORO, and PDYN. These are solid companies with solid Q1. These stocks’ Q2 earnings are happening for the next two weeks!
This is cool, let’s see if MDAI really takes off after your analysis, hope you catch the wave!
$HIT $MDAI - wait a little but they’ll get FDA approval and land a DoD contract and hospital integration. These are the only real companies I’ve found so far $SILO - will make a run up this week into the next but not a for sure thing like the other 2
Still not a Pennystock but it will be soon... $6.45 @ 2.2B market cap Way better opportunities than this trash and much better price points. CTM or MDAI for example , shit even RR leagues better  This will Crater and crash ... Catch my Buy order at $3.69 Big Bear 🐻